Article
Muscular dystrophy cell therapy : an in utero approach using human fetal mesenchymal stem cells
2009-01-01
Abstract excerpt
Duchenne muscular dystrophy (DMD) is the most prevalent genetic neuromuscular disorder and affects 1 in 3,500 live male births. Lack of the protein dystrophin in muscle fibres causes permanent muscle damage, is lethal and despite various potential therapeutic strategies aimed at restoring dystrophin expression, has no cure. As DMD affects all skeletal muscles as well as the heart, a systemic treatment would be nec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b51ab7dc-c434-5e00-a181-3dc66b1127b4
- DOI
- 10.25560/4726
